RemSleep Holdings (RMSL) Enterprise Value Growth (3y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 51.17% |
| Sep 30, 2025 | 45.81% |
| Jun 30, 2025 | 44.19% |
| Mar 31, 2025 | 49.47% |
| Dec 31, 2024 | 48.12% |
| Sep 30, 2024 | 39.07% |
| Jun 30, 2024 | -25.81% |
| Mar 31, 2024 | -66.30% |
| Dec 31, 2023 | -84.65% |
| Sep 30, 2023 | -110.59% |
| Jun 30, 2023 | -183.02% |
| Mar 31, 2023 | -79.41% |
| Dec 31, 2022 | -148.82% |
| Sep 30, 2022 | -176.99% |
| Jun 30, 2022 | -136.14% |
| Mar 31, 2022 | -349.00% |
| Dec 31, 2021 | -488.04% |
| Sep 30, 2021 | -286.46% |
| Jun 30, 2021 | -759.31% |
| Mar 31, 2021 | -44.86% |
| Dec 31, 2020 | -284.21% |
| Sep 30, 2020 | -1,107.52% |
| Dec 31, 2018 | -436.10% |
| Dec 31, 2015 | 39.09% |